CVE-2023-3835

Bug Finder MineStack Ticket create cross site scripting

Description

A vulnerability classified as problematic has been found in Bug Finder MineStack 1.0. This affects an unknown part of the file /user/ticket/create of the component Ticket Handler. The manipulation of the argument message leads to cross site scripting. It is possible to initiate the attack remotely. The identifier VDB-235161 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Category

3.5
CVSS
Severity: Low
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: Bug Finder MineStack
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.235161 third party advisory vdb entry technical description
https://vuldb.com/?ctiid.235161 signature third party advisory permissions required

Frequently Asked Questions

What is the severity of CVE-2023-3835?
CVE-2023-3835 has been scored as a low severity vulnerability.
How to fix CVE-2023-3835?
To fix CVE-2023-3835, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-3835 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-3835 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-3835?
CVE-2023-3835 affects Bug Finder MineStack.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.